Drugs Made In America Acquisition Corp.
DMAAR- Exchange
- Nasdaq
- Industry
- Blank Checks
- SEC CIK
- 0002028614
No open-market purchases or sales by Drugs Made In America Acquisition Corp. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $1.27M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Drugs Made In America Acquisition Corp. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +3 vs. Q4 2025
- Shares held
- 14.8M
- −2.11M (−12.5%) vs. Q4 2025
- Total value
- $872.3K
- −$2.15M (−71.2%) vs. Q4 2025
- New holders
- 6
- 6 more added
- Sold out
- 3
- 10 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DMAAR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 28 | $1.27M |
| Q1 2026 | 35 | $872.3K |
| Q4 2025 | 32 | $3.02M |
| Q3 2025 | 32 | $3.71M |
| Q2 2025 | 24 | $2.22M |
| Q1 2025 | 19 | $1.72M |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Drugs Made In America Acquisition Corp.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Polar Asset Management Partners Inc. | 1,900,000 | $114.0K | 0.00% | 00.0% | Unchanged |
| Hudson Bay Capital Management LP | 1,701,546 | $93.8K | 0.00% | −98,454−5.5% | Reduced |
| Highbridge Capital Management LLC | 1,044,319 | $62.6K | 0.00% | +20,207+2.0% | Added |
| Mangrove Partners | 850,000 | $51.3K | 0.00% | 00.0% | Unchanged |
| Linden Advisors LP | 850,000 | $48.9K | 0.00% | 00.0% | Unchanged |
| Clear Street Group Inc. | 711,917 | $43.0K | 0.00% | +86,482+13.8% | Added |
| Boothbay Fund Management, LLC | 695,227 | $42.0K | 0.00% | +125,227+22.0% | Added |
| Wolverine Asset Management LLC | 693,136 | $41.9K | 0.00% | +130,000+23.1% | Added |
| Toronto Dominion Bank | 690,000 | $41.4K | 0.00% | −313,000−31.2% | Reduced |
| LMR Partners LLP | 500,000 | $30.2K | 0.00% | 00.0% | Unchanged |
| Westchester Capital Management, LLC | 500,000 | $27.6K | 0.00% | 00.0% | Unchanged |
| Shaolin Capital Management LLC | 450,000 | $27.2K | 0.00% | −150,000−25.0% | Reduced |
| Rivernorth Capital Management, LLC | 417,998 | $25.2K | 0.00% | 00.0% | Unchanged |
| Whitebox Advisors LLC | 400,000 | $24.2K | 0.00% | 00.0% | Unchanged |
| RLH Capital LLC | 399,391 | $24.1K | 0.01% | +399,391 | New |
| Alpine Global Management, LLC | 362,500 | $21.9K | 0.00% | 00.0% | Unchanged |
| CNH Partners LLC | 372,322 | $20.5K | 0.00% | −7,992−2.1% | Reduced |
| Glazer Capital, LLC | 297,475 | $18.0K | 0.00% | −239,377−44.6% | Reduced |
| Aristeia Capital LLC | 264,168 | $16.0K | 0.00% | −617,548−70.0% | Reduced |
| Quarry LP | 249,391 | $15.1K | 0.00% | +149,391+149.4% | Added |
| Radcliffe Capital Management, L.P. | 231,551 | $13.3K | 0.00% | −93,549−28.8% | Reduced |
| Context Capital Management, LLC | 201,016 | $12.1K | 0.00% | −48,984−19.6% | Reduced |
| Meteora Capital, LLC | 182,581 | $11.0K | 0.00% | +180,581+9,029.1% | Added |
| BNP Paribas Arbitrage, SA | 119,686 | $7.18K | 0.00% | 00.0% | Unchanged |
| Commonwealth of Pennsylvania Public School Empls Retrmt Sys | 117,544 | $7.05K | 0.00% | +117,544 | New |
| DLD Asset Management, LP | 101,594 | $6.14K | 0.00% | 00.0% | Unchanged |
| Verition Fund Management LLC | 99,200 | $5.47K | 0.00% | −800−0.8% | Reduced |
| Periscope Capital Inc. | 75,000 | $4.50K | 0.00% | 00.0% | Unchanged |
| Lineage Point Capital LP | 50,000 | $3.02K | 0.00% | +50,000 | New |
| Gabelli Funds LLC | 49,300 | $2.98K | 0.00% | +49,300 | New |
| Gabelli & Co Investment Advisers, Inc. | 48,100 | $2.90K | 0.00% | +48,100 | New |
| Readystate Asset Management LP | 50,000 | $2.75K | 0.00% | 00.0% | Unchanged |
| Bulldog Investors, LLP | 43,364 | $2.62K | 0.00% | −86,900−66.7% | Reduced |
| StoneX Group Inc. | 42,120 | $2.54K | 0.00% | +42,120 | New |
| CSS LLC | 31,250 | – | – | 00.0% | Unchanged |
| Harraden Circle Investments, LLC | 0 | $0 | 0.00% | −1,500,000−100.0% | Sold out |
| Heights Capital Management, Inc | 0 | $0 | 0.00% | −234,109−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −117,480−100.0% | Sold out |